Quarterly report pursuant to Section 13 or 15(d)

OPTIONS, RESTRICTED STOCK UNITS AND WARRANTS (Tables)

v3.21.1
OPTIONS, RESTRICTED STOCK UNITS AND WARRANTS (Tables)
3 Months Ended
Mar. 31, 2021
OPTIONS, RESTRICTED STOCK UNITS AND WARRANTS (Tables) [Line Items]  
Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]

The following table presents information related to stock options at March 31, 2021:

 

Options Outstanding

   

Options Exercisable

 
               

Weighted

         
               

Average

   

Exercisable

 

Exercise

   

Number of

   

Remaining Life

   

Number of

 

Price

   

Options

   

In Years

   

Options

 
$ 2.51-5.00       2,187,257       8.1       1,499,428  
  5.01-7.50       1,324,447       6.3       980,179  
  7.51-10.00       203,333       8.5       100,273  
  10.01-12.50       65,000       9.1       46,249  
          3,780,037       7.5       2,626,129  

 

Options Outstanding

   

Options Exercisable

 
               

Weighted

         
               

Average

   

Exercisable

 

Exercise

   

Number of

   

Remaining Life

   

Number of

 

Price

   

Options

   

In Years

   

Options

 
$ 5.00       675,000       8.61       608,332  

 

Share-based Payment Arrangement, Option, Activity [Table Text Block]

A summary of the stock option activity and related information for the Plan for the three months ended March 31, 2021 is as follows:

 

                   

Weighted-Average

         
           

Weighted-Average

   

Remaining

   

Aggregate

 
   

Shares

   

Exercise Price

   

Contractual Term

   

Intrinsic Value

 

Outstanding at December 31, 2020

    3,568,497     $ 5.59       7.0     $ 110,961  

Grants

    489,500       4.38       10.0     $ -  

Exercised

    (9,375

)

  $ 2.96               -  

Forfeited/expired

    (268,585

)

  $ 7.53               -  

Outstanding at March 31, 2021

    3,780,037     $ 5.31       7.50     $ 308,891  

Exercisable at March 31, 2021

    2,626,129     $ 5.34       6.77     $ 228,066  

 

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

The following assumptions were used in determining the fair value of options during the three months ended March 31, 2021:

 

Risk-free interest rate

    0.83% - 0.94

%

Dividend yield

    0

%

Stock price volatility

    94.06% to 95.98

%

Expected life

 

6 years

 

Weighted average grant date fair value

  $ 4.03  

 

Schedule of Warrants or Rights, Shares Authorized, by Exercise Price Range [Table Text Block] The following table summarizes information with respect to outstanding warrants to purchase common stock of BioSig Technologies, Inc. at March 31, 2021:

Exercise

   

Number

 

Expiration

Price

   

Outstanding

 

Date

$ 4.38       548,938  

April 2021

$ 4.80       125,000  

February 2025

$ 6.16       568,910  

November 2027

$ 6.85       193,352  

July 2021 to August 2021

          1,436,200    

 

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

A summary of the warrant activity for the three months ended March 31, 2021 is as follows:

 

                   

Weighted-Average

         
           

Weighted-Average

   

Remaining

Contractual

   

Aggregate

 
   

Shares

   

Exercise Price

   

Term

   

Intrinsic Value

 

Outstanding at December 31, 2020

    1,446,200     $ 5.44       3.3     $ 1,500  

Grants

    -                          

Exercised

    -                          

Expired

    (10,000

)

  $ 3.75       -       -  

Outstanding at March 31, 2021

    1,436,200     $ 5.45       3.1     $ -  
                                 

Vested and expected to vest at March 31, 2021

    1,436,200     $ 5.45       3.1     $ -  

Exercisable at March 31, 2021

    1,436,200     $ 5.45       3.1     $ -  

 

Nonvested Restricted Stock Shares Activity [Table Text Block]

The following table summarizes the restricted stock activity for the three months ended March 31, 2021:

 

Restricted shares issued as of December 31, 2020

    218,334  

Granted

    251,000  

Vested and issued

    (23,334

)

Forfeited

    (100,000

)

Vested restricted shares as of March 31, 2021

    -  

Unvested restricted shares as of March 31, 2021

    346,000  

 

Restricted shares issued as of December 31, 2020

    1,420,716  

Granted

    -  

Forfeited

    (82,716

)

  Total

    1,338,000  

Comprised of:

       

Vested restricted shares as of March 31, 2021

    698,000  

Unvested restricted shares as of March 31, 2021

    640,000  

 

Schedule of Warrants or Rights, Shares Authorized, Exercise Price Range [Table Text Block]

The following table presents information related to warrants (ViralClear) at March 31, 2021:

 

Exercise

   

Number

 

Expiration

Price

   

Outstanding

 

Date

$ 5.00       473,772  

November 2027

  10.00       6,575  

May 2025

          480,347    

 

Viral Clear [Member]  
OPTIONS, RESTRICTED STOCK UNITS AND WARRANTS (Tables) [Line Items]  
Share-based Payment Arrangement, Option, Activity [Table Text Block]

A summary of the stock option activity and related information for the ViralClear Plan for the three months ended March 31, 2021 is as follows:

 

                   

Weighted-Average

 
           

Weighted-Average

   

Remaining

Contractual

 
   

Shares

   

Exercise Price

   

Term

 

Outstanding at December 31, 2020

    1,527,666     $ 5.00       3.96  

Grants

    -                  

Exercised

    -                  

Forfeited/expired

    (852,666

)

  $ 5.00          

Outstanding at March 31, 2021

    675,000     $ 5.00       8.61  

Exercisable at March 31, 2021

    608,332     $ 5.00       8.57